EVALI and the Pulmonary Toxicity of Electronic Cigarettes: A Review
- PMID: 32246394
- PMCID: PMC7351931
- DOI: 10.1007/s11606-020-05813-2
EVALI and the Pulmonary Toxicity of Electronic Cigarettes: A Review
Abstract
Electronic cigarettes are a novel and emerging product increasingly used by the general public. However, despite their popularity, they remain poorly studied and with likely serious health risks. EVALI, or "electronic cigarette or vaping product use-associated lung injury," is a recently described entity at the forefront of current investigations. Though EVALI has been linked to vitamin E acetate, a constituent of THC vaping products, electronic cigarettes likely pose a host of other pulmonary toxicities. The presentation, diagnostic work-up, treatment, and pathophysiology of EVALI are herein described, as well as the general pulmonary toxicity profile of electronic cigarettes.
Conflict of interest statement
The authors declare that they do not have a conflict of interest.
Figures
References
-
- Consumer Advocates for Smoke Free Alternatives Association. A Historical Timeline of Electronic Cigarettes. Accessed 9/9/19. http://www.casaa.org/historical-timeline-of-electronic-cigarettes
-
- Surgeon General. Get The Facts. Accessed 9/17/19. https://e-cigarettes.surgeongeneral.gov/getthefacts.html
-
- 2018 National Youth Tobacco Survey. A Startling Rise in Youth E-cigarette Use. Accessed 9/17/19. https://www.fda.gov/tobacco-products/youth-and-tobacco/2018-nyts-data-st...
-
- Centers for Disease Control and Prevention. Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping. Accessed 9/3/19. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-d...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
